COST-EFFECTIVENESS OF RITUXIMAB IN THE TREATMENT OF RA PATIENTS IN THE NETHERLANDS

被引：0
|
作者：
Diamantopoulos, A. [1 ]
Kievit, W. [2 ]
De Vries, R. [3 ]
Pompen, M. [3 ]
机构：
[1] Symmetron Ltd, Elstree, Herts, England
[2] Dutch Rheumatoid Arthritis Monitoring Register, Nijmegen, Netherlands
[3] Roche, Woerden, Netherlands
来源：
VALUE IN HEALTH | 2011年 / 14卷 / 07期
关键词：
D O I：
10.1016/j.jval.2011.08.435
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A311 / A311
页数：1
相关论文
共 50 条
  • [41] Cost-effectiveness of nonavalent HPV vaccination in the Netherlands
    Palmer, Cody
    Dolk, Christiaan
    Sabale, Ugne
    Wang, Wei
    Saxena, Kunal
    EXPERT REVIEW OF VACCINES, 2024, 23 (01) : 312 - 323
  • [42] COST-EFFECTIVENESS OF INFANT PNEUMOCOCCAL VACCINATION IN THE NETHERLANDS
    Vemer, P.
    Postma, M. J.
    VALUE IN HEALTH, 2013, 16 (07) : A334 - A334
  • [43] COST-EFFECTIVENESS OF MENINSOCOCCAL B VACCINATION IN THE NETHERLANDS
    Zeevat, F.
    Joost, S.
    Westra, T. A.
    Wilschut, J. C.
    van Sorge, N.
    Boersma, C.
    Postma, M. J.
    VALUE IN HEALTH, 2022, 25 (12) : S177 - S177
  • [44] Cost-Effectiveness of Pediatric Influenza Vaccination in The Netherlands
    de Boer, Pieter T.
    Nagy, Lisa
    Dolk, Franklin C. K.
    Wilschut, Jan C.
    Pitman, Richard
    Postma, Maarten J.
    VALUE IN HEALTH, 2021, 24 (01) : 19 - 31
  • [45] Effectiveness and cost-effectiveness of early screening and treatment of malnourished patients
    Kruizenga, HM
    Van Tulder, MW
    Seidell, JC
    Thijs, A
    Ader, HJ
    van der Schueren, MAEV
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2005, 82 (05): : 1082 - 1089
  • [46] COST-EFFECTIVENESS ANALYSIS OF RITUXIMAB USE IN TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA IN UKRAINE
    Mandrik, O.
    Zalis'ka, O.
    Severens, J. L.
    VALUE IN HEALTH, 2012, 15 (04) : A221 - A221
  • [47] COST-EFFECTIVENESS OF RITUXIMAB VS ADALIMUMAB IN THE TREATMENT OF MODERATE TO SEVERE RHEUMATOID ARTHRITIS
    Bynum, L. A.
    Joshi, N.
    VALUE IN HEALTH, 2010, 13 (03) : A126 - A126
  • [48] COST-EFFECTIVENESS ANALYSIS OF ETANERCEPT AND INFLIXIMAB IN THE TREATMENT OF RHEUMATOID ARTHRITIS (RA) IN SPAIN
    Guijarro, P.
    Crespo, C.
    Brosa, M.
    VALUE IN HEALTH, 2012, 15 (07) : A448 - A448
  • [49] Cost-effectiveness of rituximab maintenance therapy for patients with follicular lymphoma: The Spanish perspective
    Gomez Codina, J.
    Provencio, M.
    Rueda, A.
    Capote, F.
    Carbonell, F.
    Conde, E.
    Fernandez Ranada, J.
    Giraldo, P.
    Rios, E.
    Varela, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [50] Cost-effectiveness Analysis for Apixaban in the Acute Treatment and Prevention of Venous Thromboembolism in the Netherlands
    de Jong, Lisa A.
    Dvortsin, Evgeni
    Janssen, Kristel J.
    Postma, Maarten J.
    CLINICAL THERAPEUTICS, 2017, 39 (02) : 288 - 302
12345